Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
G.D.R. Monsanto Division in 2008. The club was relegated back to the Third Division for the 2010–11 season, where it won the Series D league, and will compete in the Second Division again in 2011–12. Each season, the team competes in the Portuguese Cup. G.D.R. Monsanto play their home matches in Campo do Pião, Monsanto. The stadium's capacity is 1000. "As of 20 June 2011." G.D.R. Monsanto G.D.R. Monsanto is a Portuguese football club based in the village of Monsanto in the municipality of Idanha-a-Nova in east Portugal. They currently play in one of eight regional leagues in the Portuguese Third Division